Fukushima, Japan

Yukiko Oguchi


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yukiko Oguchi: An Innovator in Cardiovascular Research

Introduction:

Yukiko Oguchi is a notable inventor based in Fukushima, Japan. She has made significant contributions to the field of medicinal chemistry, with a focus on developing innovative solutions for cardiovascular health. With one patent to her name, her work exemplifies the spirit of innovation in the scientific community.

Latest Patents:

Yukiko holds a patent for a compound known as 4,7-dihydroisothiazolo(5,4-b)pyridine derivatives, aimed at enhancing cardiovascular health. This invention includes a 4,7-dihydroisothiazole[5,4-b]pyridine derivative represented by a specific general formula wherein R^1 represents a possibly substituted alkyl group. This innovative compound has the potential to provide new therapeutic opportunities in the treatment of cardiovascular conditions.

Career Highlights:

Yukiko works for Toa Eiyo Ltd., a company dedicated to advancing medical technologies and pharmaceuticals. Her research focuses on creating effective drug formulations that can improve patient outcomes in cardiovascular diseases. Her dedication to innovative solutions makes her a valuable asset to her organization and the broader scientific community.

Collaborations:

Throughout her career, Yukiko has collaborated with esteemed colleagues, including Shin-ichi Yamada and Takao Goto. Their combined expertise and commitment to research have played a crucial role in her endeavors to innovate and develop groundbreaking medical solutions.

Conclusion:

Yukiko Oguchi stands out as an innovative inventor in the field of cardiovascular research. With her impactful patent and meaningful collaborations, she contributes significantly to the advancement of healthcare technologies. As she continues her work at Toa Eiyo Ltd., Yukiko is poised to make further contributions that could change the landscape of cardiovascular treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…